Be Clinical offers science-backed skincare products via ecommerce
Be Clinical, a startup founded in 2023, operates an ecommerce platform specializing in science-backed skincare products. According to Inc42, the company focuses on developing solutions for various skin conditions and has expanded its product range since its launch.
Editor, Lazyfounder

What Be Clinical does
Be Clinical is an ecommerce platform that develops and sells science-backed skincare products, according to Inc42. The company was founded in 2023 and initially focused on solutions for specific skin conditions, later expanding its product offerings.
The startup’s model relies on delivering skincare products directly to consumers through its online platform. It emphasizes scientifically supported formulations as a key differentiator in the skincare market.
Data and intelligence platform insights
Inc42 provides structured data on Be Clinical, including funding history, financials, ownership details, and regulatory filings. This information is sourced from public records, statutory filings, and proprietary research.
The platform also offers real-time updates on business signals such as funding rounds, hiring momentum, and leadership changes. These updates are reportedly available within 24 hours of confirmation.
What this means
Lazyfounder analysis — our interpretation, not reported fact.
Be Clinical’s focus on science-backed skincare via ecommerce reflects a growing trend in the direct-to-consumer health and wellness space. For founders and operators, this model highlights the potential of combining specialized product development with online retail, particularly in markets where consumer demand for evidence-based skincare is rising. The availability of structured data on startups like Be Clinical also underscores the value of transparency tools for competitors, investors, and industry analysts.
Sources
This story is an original summary drafted with AI by Lazyfounder from the reporting listed above and checked by automated validation. Facts are attributed to their original publishers; sections marked as analysis are Lazyfounder's. Where a source is in another language, facts were machine-translated and quotations are reported, not reproduced. Read the original coverage via the links, and see our AI policy and corrections policy.
About the author
Editor, Lazyfounder
Tarun Mottlia edits LazyFounders, covering Indian startups, funding rounds, AI and product launches. Every story on the site is AI-assisted and checked against its cited sources before publication.
More stories by Tarun MottliaGet the LazyFounder Brief
Startup, funding and AI news in a five-minute read. Join the early-access list.


